How Avid Bioservices Beat Wall Street Estimates in Q4
Like most stocks, Avid Bioservices (NASDAQ: CDMO) plunged earlier this year in the wake of the COVID-19 pandemic. However, the contract development and manufacturing organization (CDMO) has bounced back nicely and isn't too far away from its share price at the beginning of 2020.
The company could get some help with its rebound after announcing its fiscal 2020 fourth-quarter and full-year results after the market closed on Tuesday. Here are the highlights from Avid's Q4 update.
Image source: Getty Images.
Source Fool.com
